Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Liquidia Corp Create: Alert

All | News | Filings
Date FiledTypeDescription
08/21/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
08/10/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/10/2023 8-K Quarterly results
Docs: "Liquidia Corporation Reports Second Quarter 2023 Financial Results and Provides Corporate Update MORRISVILLE, N.C., August 10, 2023"
07/27/2023 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Liquidia Submits Amendment to Add PH-ILD Indication to Tentatively Approved NDA for YUTREPIA™ Inhalation Powder"
07/24/2023 8-K Quarterly results
07/17/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
06/29/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
06/16/2023 8-K Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits  Interactive Data
06/08/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
05/08/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/05/2023 SC 13G BlackRock Inc. reports a 5% stake in LIQUIDIA CORP
05/04/2023 8-K Quarterly results
Docs: "Liquidia Corporation Reports First Quarter 2023 Financial Results and Provides Corporate Update MORRISVILLE, N.C., May 4, 2023",
"Liquidia Corporation script for the conference call and online webcast held on May 4, 2023"
04/28/2023 ARS Form ARS - Annual Report to Security Holders:
04/28/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/28/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/17/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
04/03/2023 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Other Events, Financial Statement...
Docs: "Liquidia and GSK Restructure License to PRINT Technology for Inhaled Applications"
03/22/2023 8-K Other Events  Interactive Data
03/20/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/20/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/20/2023 10-K Annual Report for the period ended December 31, 2022
03/16/2023 8-K Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Financial Statements and Exhibits ...
Docs: "Liquidia Corporation Reports Full Year 2022 Financial Results and Provides Corporate Update"
02/14/2023 SC 13G/A Manning Paul B reports a 9.3% stake in Liquidia Corporation
02/13/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/01/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/30/2023 8-K Termination of a Material Definitive Agreement  Interactive Data
01/09/2023 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Ob...
Docs: "Liquidia Enters Into a Revenue Interest Financing Agreement With HealthCare Royalty for Up to $100 Million -"
12/05/2022 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Liquidia Announces Collaboration to Develop a New Infusion Pump for Subcutaneous Delivery of Treprostinil Injection to Treat Pulmonary Arterial Hypertension -"
11/25/2022 8-K Entry into a Material Definitive Agreement  Interactive Data
11/08/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/08/2022 8-K Quarterly results
Docs: "Liquidia Reports Third Quarter 2022 Financial Results and Provides Corporate Update"
10/28/2022 8-K Quarterly results
08/11/2022 10-Q Quarterly Report for the period ended June 30, 2022
07/19/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Liquidia Receives Favorable Ruling in Inter Partes Review against United Therapeutics Patent"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy